Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (15 ops.)
Latest filing published 14 May 2026 for Apellis Pharmaceuticals, Inc.. Read the official filing
Filing timeline
BuySaleJames George Chopas
Insider track record
Disclosed buys
0
Disclosed sells
15
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
James George Chopas: trading record in brief
James George Chopas (finance chief) discloses dealings in Apellis Pharmaceuticals, Inc. to SEC (Form 4). Over a trading history stretching from 30 August 2021 to 14 May 2026, the count stands at 30 filings.
Every open-market trade on record is a sale: 15 sales worth €289k. The rest of the record consists of 14 share grants. 2026 to date brings no purchases and 3 sales.
On 14 May 2026 came the latest disclosure, a transaction in Apellis Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to James George Chopas
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations30 total
65,955 sharesCommon StockSEC:0001193125-26-224627:0
16,150 shares0Common StockSEC:0001492422-26-000078:0
2,064 shares@ US$21.765410.3% of flowCommon StockSEC:0001492422-26-000060:0
726 shares@ US$19.79293.3% of flowCommon StockSEC:0001492422-26-000044:0
873 shares@ US$22.18724.4% of flowCommon StockSEC:0001492422-26-000031:0
189 shares@ US$24.1921.3% of flowCommon StockSEC:0001492422-25-000005:0
548 shares@ US$28.0774.4% of flowCommon StockSEC:0001127602-25-021110:0
6,250 shares0Common StockSEC:0001127602-25-017836:0
183 shares@ US$24.82371.4% of flowCommon StockSEC:0001127602-25-009738:0
1,096 shares@ US$30.425511.1% of flowCommon StockSEC:0001127602-25-001829:0
715 shares@ US$29.95827.2% of flowCommon StockSEC:0001127602-25-001614:0
12,591 shares0Common StockSEC:0001127602-25-001614:1
783 shares@ US$28.70217.6% of flowCommon StockSEC:0001127602-25-001184:0
192 shares@ US$36.2062.2% of flowCommon StockSEC:0001127602-24-024074:0
550 shares@ US$39.4916.8% of flowCommon StockSEC:0001127602-24-023392:0
184 shares@ US$56.4613.3% of flowCommon StockSEC:0001127602-24-010416:0
1,061 shares@ US$64.99621.9% of flowCommon StockSEC:0001127602-24-001928:0
8,312 shares0Common StockSEC:0001127602-24-001441:0
132 shares@ US$46.03622.0% of flowCommon StockSEC:0001127602-23-026188:0
2,500 shares0Common StockSEC:0001127602-23-024308:0
551 shares@ US$41.2267.2% of flowCommon StockSEC:0001127602-23-023568:0
4,044 shares0Common StockSEC:0000899243-23-005785:0
919 shares@ US$52.0515.3% of flowCommon StockSEC:0001127602-23-002111:0
9,621 shares0Common StockSEC:0001127602-23-001491:0
130 shares@ US$58.002.7% of flowCommon StockSEC:0001127602-22-024299:0
25 of 30 declarations
